Screening of key genes associated with R-CHOP immunochemotherapy and construction of a prognostic risk model in diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) is a common subtype of non-Hodgkin lymphoma, which is curable in the majority of patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) immunochemotherapy. However, the therapeutic mechanism of R-CHOP has not been...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ran, Chen, Zhi, Wang, Shujun, Zhao, Gang, Gu, Yan, Han, Qi, Chen, Baoan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755150/
https://www.ncbi.nlm.nih.gov/pubmed/31485671
http://dx.doi.org/10.3892/mmr.2019.10627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755150/
https://www.ncbi.nlm.nih.gov/pubmed/31485671
http://dx.doi.org/10.3892/mmr.2019.10627

Ejemplares similares